Global Inactivated Poultry Vaccine Market Insights, Forecast to 2034
Inactivated poultry vaccines belong to a class of preventative biologics called "subunit/inactivated virus vaccines." They contain only parts of the virus rather than the entire pathogen. These components are isolated from disease cells and weakened or killed before use in humans and animals so they won't cause illness but still trigger immune responses to protect against subsequent exposure to live viruses.
Global Inactivated Poultry Vaccine market is expected to reach to US$ 3205 million in 2024, with a positive growth of %, compared with US$ 3068 million in 2022. Backed with the increasing demand from downstream industries, Inactivated Poultry Vaccine industry is evaluated to reach US$ 4173.7 million in 2029. The CAGR will be 4.5% during 2024 to 2029.
The global inactivated poultry vaccine market represents one segment within the broader animal vaccines industry that includes subcategories based on species and diseases targeted. This particular subset serves as a critical component in global efforts to manage avian influenza outbreaks caused by deadly H5N8 and H5N6 strains spreading rapidly across continents posing serious threats to human and animal health. To combat this devastating threat, governments around the globe encourage research & development (R&D) investment in effective vaccines adaptable to different regions and birds breeds while companies strive to meet escalating consumer needs driving accelerated evolution towards safer, stronger formulations guaranteeing enhanced protection versus emerging virulent strains. Ongoing studies explore advanced manufacturing techniques and adjuvants promising increased potency and longevity, expanding opportunities for market expansion beyond current offerings leveraged mainly in Asian-Pacific countries where demand remains consistently strong. Suppliers maintain competitive edge via continuous innovation refining production processes ensuring quality performance under diverse conditions extending lifespans maximizing efficiency minimizing waste amidst persistent supply chain complexities faced daily by every participant operating within volatile environments rife with unpredictability testing resilience throughout extended value chains impacting everyone along each step necessitating flexibility adaptability sustaining viability securing future success.
Report Covers
This report presents an overview of global Inactivated Poultry Vaccine market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Inactivated Poultry Vaccine market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Zoetis
Merck Animal Health
Boehringer Ingelheim
Elanco Animal Health
Phibro Animal Health
Virbac
Hipra
Venkys
Biovet
Ringpu Biology
Ceva Corporate
KM Biologics
Vaxxinova
Japfa Comfeed Indonesia
Nisseiken
Segment by Type
Liquid Vaccines
Freeze-Dried Vaccines
Segment by Application
Avian Encephalomyelitis
Chicken Anaemia
Egg Drop Syndrome
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Inactivated Poultry Vaccine plant distribution, commercial date of Inactivated Poultry Vaccine, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Inactivated Poultry Vaccine introduction, etc. Inactivated Poultry Vaccine Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Inactivated Poultry Vaccine
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Table of Content
1 Study Coverage
1.1 Inactivated Poultry Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Inactivated Poultry Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Liquid Vaccines
1.2.3 Freeze-Dried Vaccines
1.3 Market by Application
1.3.1 Global Inactivated Poultry Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Avian Encephalomyelitis
1.3.3 Chicken Anaemia
1.3.4 Egg Drop Syndrome
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Inactivated Poultry Vaccine Sales Estimates and Forecasts 2018-2029
2.2 Global Inactivated Poultry Vaccine Revenue by Region
2.2.1 Global Inactivated Poultry Vaccine Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Inactivated Poultry Vaccine Revenue by Region (2018-2024)
2.2.3 Global Inactivated Poultry Vaccine Revenue by Region (2024-2029)
2.2.4 Global Inactivated Poultry Vaccine Revenue Market Share by Region (2018-2029)
2.3 Global Inactivated Poultry Vaccine Sales Estimates and Forecasts 2018-2029
2.4 Global Inactivated Poultry Vaccine Sales by Region
2.4.1 Global Inactivated Poultry Vaccine Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Inactivated Poultry Vaccine Sales by Region (2018-2024)
2.4.3 Global Inactivated Poultry Vaccine Sales by Region (2024-2029)
2.4.4 Global Inactivated Poultry Vaccine Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Inactivated Poultry Vaccine Sales by Manufacturers
3.1.1 Global Inactivated Poultry Vaccine Sales by Manufacturers (2018-2024)
3.1.2 Global Inactivated Poultry Vaccine Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inactivated Poultry Vaccine in 2022
3.2 Global Inactivated Poultry Vaccine Revenue by Manufacturers
3.2.1 Global Inactivated Poultry Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Inactivated Poultry Vaccine Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Inactivated Poultry Vaccine Revenue in 2022
3.3 Global Key Players of Inactivated Poultry Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Inactivated Poultry Vaccine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Inactivated Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Inactivated Poultry Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Inactivated Poultry Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Inactivated Poultry Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Inactivated Poultry Vaccine Sales by Type
4.1.1 Global Inactivated Poultry Vaccine Historical Sales by Type (2018-2024)
4.1.2 Global Inactivated Poultry Vaccine Forecasted Sales by Type (2024-2029)
4.1.3 Global Inactivated Poultry Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Inactivated Poultry Vaccine Revenue by Type
4.2.1 Global Inactivated Poultry Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Inactivated Poultry Vaccine Forecasted Revenue by Type (2024-2029)
4.2.3 Global Inactivated Poultry Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Inactivated Poultry Vaccine Price by Type
4.3.1 Global Inactivated Poultry Vaccine Price by Type (2018-2024)
4.3.2 Global Inactivated Poultry Vaccine Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Inactivated Poultry Vaccine Sales by Application
5.1.1 Global Inactivated Poultry Vaccine Historical Sales by Application (2018-2024)
5.1.2 Global Inactivated Poultry Vaccine Forecasted Sales by Application (2024-2029)
5.1.3 Global Inactivated Poultry Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Inactivated Poultry Vaccine Revenue by Application
5.2.1 Global Inactivated Poultry Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Inactivated Poultry Vaccine Forecasted Revenue by Application (2024-2029)
5.2.3 Global Inactivated Poultry Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Inactivated Poultry Vaccine Price by Application
5.3.1 Global Inactivated Poultry Vaccine Price by Application (2018-2024)
5.3.2 Global Inactivated Poultry Vaccine Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Inactivated Poultry Vaccine Market Size by Type
6.1.1 US & Canada Inactivated Poultry Vaccine Sales by Type (2018-2029)
6.1.2 US & Canada Inactivated Poultry Vaccine Revenue by Type (2018-2029)
6.2 US & Canada Inactivated Poultry Vaccine Market Size by Application
6.2.1 US & Canada Inactivated Poultry Vaccine Sales by Application (2018-2029)
6.2.2 US & Canada Inactivated Poultry Vaccine Revenue by Application (2018-2029)
6.3 US & Canada Inactivated Poultry Vaccine Market Size by Country
6.3.1 US & Canada Inactivated Poultry Vaccine Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Inactivated Poultry Vaccine Sales by Country (2018-2029)
6.3.3 US & Canada Inactivated Poultry Vaccine Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Inactivated Poultry Vaccine Market Size by Type
7.1.1 Europe Inactivated Poultry Vaccine Sales by Type (2018-2029)
7.1.2 Europe Inactivated Poultry Vaccine Revenue by Type (2018-2029)
7.2 Europe Inactivated Poultry Vaccine Market Size by Application
7.2.1 Europe Inactivated Poultry Vaccine Sales by Application (2018-2029)
7.2.2 Europe Inactivated Poultry Vaccine Revenue by Application (2018-2029)
7.3 Europe Inactivated Poultry Vaccine Market Size by Country
7.3.1 Europe Inactivated Poultry Vaccine Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Inactivated Poultry Vaccine Sales by Country (2018-2029)
7.3.3 Europe Inactivated Poultry Vaccine Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Inactivated Poultry Vaccine Market Size
8.1.1 China Inactivated Poultry Vaccine Sales (2018-2029)
8.1.2 China Inactivated Poultry Vaccine Revenue (2018-2029)
8.2 China Inactivated Poultry Vaccine Market Size by Application
8.2.1 China Inactivated Poultry Vaccine Sales by Application (2018-2029)
8.2.2 China Inactivated Poultry Vaccine Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Inactivated Poultry Vaccine Market Size by Type
9.1.1 Asia Inactivated Poultry Vaccine Sales by Type (2018-2029)
9.1.2 Asia Inactivated Poultry Vaccine Revenue by Type (2018-2029)
9.2 Asia Inactivated Poultry Vaccine Market Size by Application
9.2.1 Asia Inactivated Poultry Vaccine Sales by Application (2018-2029)
9.2.2 Asia Inactivated Poultry Vaccine Revenue by Application (2018-2029)
9.3 Asia Inactivated Poultry Vaccine Sales by Region
9.3.1 Asia Inactivated Poultry Vaccine Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Inactivated Poultry Vaccine Revenue by Region (2018-2029)
9.3.3 Asia Inactivated Poultry Vaccine Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Inactivated Poultry Vaccine Market Size by Type
10.1.1 Middle East, Africa and Latin America Inactivated Poultry Vaccine Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Inactivated Poultry Vaccine Market Size by Application
10.2.1 Middle East, Africa and Latin America Inactivated Poultry Vaccine Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Inactivated Poultry Vaccine Sales by Country
10.3.1 Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Inactivated Poultry Vaccine Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Zoetis
11.1.1 Zoetis Company Information
11.1.2 Zoetis Overview
11.1.3 Zoetis Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Zoetis Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Zoetis Recent Developments
11.2 Merck Animal Health
11.2.1 Merck Animal Health Company Information
11.2.2 Merck Animal Health Overview
11.2.3 Merck Animal Health Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck Animal Health Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Animal Health Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Boehringer Ingelheim Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Boehringer Ingelheim Recent Developments
11.4 Elanco Animal Health
11.4.1 Elanco Animal Health Company Information
11.4.2 Elanco Animal Health Overview
11.4.3 Elanco Animal Health Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Elanco Animal Health Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Elanco Animal Health Recent Developments
11.5 Phibro Animal Health
11.5.1 Phibro Animal Health Company Information
11.5.2 Phibro Animal Health Overview
11.5.3 Phibro Animal Health Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Phibro Animal Health Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Phibro Animal Health Recent Developments
11.6 Virbac
11.6.1 Virbac Company Information
11.6.2 Virbac Overview
11.6.3 Virbac Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Virbac Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Virbac Recent Developments
11.7 Hipra
11.7.1 Hipra Company Information
11.7.2 Hipra Overview
11.7.3 Hipra Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Hipra Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Hipra Recent Developments
11.8 Venkys
11.8.1 Venkys Company Information
11.8.2 Venkys Overview
11.8.3 Venkys Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Venkys Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Venkys Recent Developments
11.9 Biovet
11.9.1 Biovet Company Information
11.9.2 Biovet Overview
11.9.3 Biovet Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Biovet Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Biovet Recent Developments
11.10 Ringpu Biology
11.10.1 Ringpu Biology Company Information
11.10.2 Ringpu Biology Overview
11.10.3 Ringpu Biology Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Ringpu Biology Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ringpu Biology Recent Developments
11.11 Ceva Corporate
11.11.1 Ceva Corporate Company Information
11.11.2 Ceva Corporate Overview
11.11.3 Ceva Corporate Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Ceva Corporate Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Ceva Corporate Recent Developments
11.12 KM Biologics
11.12.1 KM Biologics Company Information
11.12.2 KM Biologics Overview
11.12.3 KM Biologics Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 KM Biologics Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 KM Biologics Recent Developments
11.13 Vaxxinova
11.13.1 Vaxxinova Company Information
11.13.2 Vaxxinova Overview
11.13.3 Vaxxinova Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Vaxxinova Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Vaxxinova Recent Developments
11.14 Japfa Comfeed Indonesia
11.14.1 Japfa Comfeed Indonesia Company Information
11.14.2 Japfa Comfeed Indonesia Overview
11.14.3 Japfa Comfeed Indonesia Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Japfa Comfeed Indonesia Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Japfa Comfeed Indonesia Recent Developments
11.15 Nisseiken
11.15.1 Nisseiken Company Information
11.15.2 Nisseiken Overview
11.15.3 Nisseiken Inactivated Poultry Vaccine Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Nisseiken Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Nisseiken Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Inactivated Poultry Vaccine Industry Chain Analysis
12.2 Inactivated Poultry Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Inactivated Poultry Vaccine Production Mode & Process
12.4 Inactivated Poultry Vaccine Sales and Marketing
12.4.1 Inactivated Poultry Vaccine Sales Channels
12.4.2 Inactivated Poultry Vaccine Distributors
12.5 Inactivated Poultry Vaccine Customers
13 Market Dynamics
13.1 Inactivated Poultry Vaccine Industry Trends
13.2 Inactivated Poultry Vaccine Market Drivers
13.3 Inactivated Poultry Vaccine Market Challenges
13.4 Inactivated Poultry Vaccine Market Restraints
14 Key Findings in The Global Inactivated Poultry Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figure
List of Tables
Table 1. Global Inactivated Poultry Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Liquid Vaccines
Table 3. Major Manufacturers of Freeze-Dried Vaccines
Table 4. Global Inactivated Poultry Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Inactivated Poultry Vaccine Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Inactivated Poultry Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Inactivated Poultry Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Inactivated Poultry Vaccine Revenue Market Share by Region (2018-2024)
Table 9. Global Inactivated Poultry Vaccine Revenue Market Share by Region (2024-2029)
Table 10. Global Inactivated Poultry Vaccine Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Inactivated Poultry Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Inactivated Poultry Vaccine Sales by Region (2024-2029) & (K Units)
Table 13. Global Inactivated Poultry Vaccine Sales Market Share by Region (2018-2024)
Table 14. Global Inactivated Poultry Vaccine Sales Market Share by Region (2024-2029)
Table 15. Global Inactivated Poultry Vaccine Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Inactivated Poultry Vaccine Sales Share by Manufacturers (2018-2024)
Table 17. Global Inactivated Poultry Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Inactivated Poultry Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Inactivated Poultry Vaccine, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Inactivated Poultry Vaccine Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Inactivated Poultry Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Inactivated Poultry Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Inactivated Poultry Vaccine as of 2022)
Table 23. Global Key Manufacturers of Inactivated Poultry Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Inactivated Poultry Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Inactivated Poultry Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Inactivated Poultry Vaccine Sales by Type (2018-2024) & (K Units)
Table 28. Global Inactivated Poultry Vaccine Sales by Type (2024-2029) & (K Units)
Table 29. Global Inactivated Poultry Vaccine Sales Share by Type (2018-2024)
Table 30. Global Inactivated Poultry Vaccine Sales Share by Type (2024-2029)
Table 31. Global Inactivated Poultry Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Inactivated Poultry Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Inactivated Poultry Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Inactivated Poultry Vaccine Revenue Share by Type (2024-2029)
Table 35. Inactivated Poultry Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Inactivated Poultry Vaccine Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Inactivated Poultry Vaccine Sales by Application (2018-2024) & (K Units)
Table 38. Global Inactivated Poultry Vaccine Sales by Application (2024-2029) & (K Units)
Table 39. Global Inactivated Poultry Vaccine Sales Share by Application (2018-2024)
Table 40. Global Inactivated Poultry Vaccine Sales Share by Application (2024-2029)
Table 41. Global Inactivated Poultry Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Inactivated Poultry Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Inactivated Poultry Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Inactivated Poultry Vaccine Revenue Share by Application (2024-2029)
Table 45. Inactivated Poultry Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Inactivated Poultry Vaccine Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Inactivated Poultry Vaccine Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Inactivated Poultry Vaccine Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Inactivated Poultry Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Inactivated Poultry Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Inactivated Poultry Vaccine Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Inactivated Poultry Vaccine Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Inactivated Poultry Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Inactivated Poultry Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Inactivated Poultry Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Inactivated Poultry Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Inactivated Poultry Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Inactivated Poultry Vaccine Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Inactivated Poultry Vaccine Sales by Country (2024-2029) & (K Units)
Table 60. Europe Inactivated Poultry Vaccine Sales by Type (2018-2024) & (K Units)
Table 61. Europe Inactivated Poultry Vaccine Sales by Type (2024-2029) & (K Units)
Table 62. Europe Inactivated Poultry Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Inactivated Poultry Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Inactivated Poultry Vaccine Sales by Application (2018-2024) & (K Units)
Table 65. Europe Inactivated Poultry Vaccine Sales by Application (2024-2029) & (K Units)
Table 66. Europe Inactivated Poultry Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Inactivated Poultry Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Inactivated Poultry Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Inactivated Poultry Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Inactivated Poultry Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Inactivated Poultry Vaccine Sales by Country (2018-2024) & (K Units)
Table 72. Europe Inactivated Poultry Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. China Inactivated Poultry Vaccine Sales by Type (2018-2024) & (K Units)
Table 74. China Inactivated Poultry Vaccine Sales by Type (2024-2029) & (K Units)
Table 75. China Inactivated Poultry Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Inactivated Poultry Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Inactivated Poultry Vaccine Sales by Application (2018-2024) & (K Units)
Table 78. China Inactivated Poultry Vaccine Sales by Application (2024-2029) & (K Units)
Table 79. China Inactivated Poultry Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Inactivated Poultry Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Inactivated Poultry Vaccine Sales by Type (2018-2024) & (K Units)
Table 82. Asia Inactivated Poultry Vaccine Sales by Type (2024-2029) & (K Units)
Table 83. Asia Inactivated Poultry Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Inactivated Poultry Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Inactivated Poultry Vaccine Sales by Application (2018-2024) & (K Units)
Table 86. Asia Inactivated Poultry Vaccine Sales by Application (2024-2029) & (K Units)
Table 87. Asia Inactivated Poultry Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Inactivated Poultry Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Inactivated Poultry Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Inactivated Poultry Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Inactivated Poultry Vaccine Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Inactivated Poultry Vaccine Sales by Region (2018-2024) & (K Units)
Table 93. Asia Inactivated Poultry Vaccine Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Inactivated Poultry Vaccine Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Inactivated Poultry Vaccine Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Inactivated Poultry Vaccine Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Inactivated Poultry Vaccine Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Inactivated Poultry Vaccine Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Inactivated Poultry Vaccine Sales by Country (2024-2029) & (K Units)
Table 107. Zoetis Company Information
Table 108. Zoetis Description and Major Businesses
Table 109. Zoetis Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Zoetis Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Zoetis Recent Developments
Table 112. Merck Animal Health Company Information
Table 113. Merck Animal Health Description and Major Businesses
Table 114. Merck Animal Health Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Merck Animal Health Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Animal Health Recent Developments
Table 117. Boehringer Ingelheim Company Information
Table 118. Boehringer Ingelheim Description and Major Businesses
Table 119. Boehringer Ingelheim Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Boehringer Ingelheim Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Boehringer Ingelheim Recent Developments
Table 122. Elanco Animal Health Company Information
Table 123. Elanco Animal Health Description and Major Businesses
Table 124. Elanco Animal Health Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Elanco Animal Health Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Elanco Animal Health Recent Developments
Table 127. Phibro Animal Health Company Information
Table 128. Phibro Animal Health Description and Major Businesses
Table 129. Phibro Animal Health Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Phibro Animal Health Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Phibro Animal Health Recent Developments
Table 132. Virbac Company Information
Table 133. Virbac Description and Major Businesses
Table 134. Virbac Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Virbac Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Virbac Recent Developments
Table 137. Hipra Company Information
Table 138. Hipra Description and Major Businesses
Table 139. Hipra Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Hipra Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Hipra Recent Developments
Table 142. Venkys Company Information
Table 143. Venkys Description and Major Businesses
Table 144. Venkys Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Venkys Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Venkys Recent Developments
Table 147. Biovet Company Information
Table 148. Biovet Description and Major Businesses
Table 149. Biovet Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Biovet Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Biovet Recent Developments
Table 152. Ringpu Biology Company Information
Table 153. Ringpu Biology Description and Major Businesses
Table 154. Ringpu Biology Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Ringpu Biology Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Ringpu Biology Recent Developments
Table 157. Ceva Corporate Company Information
Table 158. Ceva Corporate Description and Major Businesses
Table 159. Ceva Corporate Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Ceva Corporate Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Ceva Corporate Recent Developments
Table 162. KM Biologics Company Information
Table 163. KM Biologics Description and Major Businesses
Table 164. KM Biologics Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. KM Biologics Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. KM Biologics Recent Developments
Table 167. Vaxxinova Company Information
Table 168. Vaxxinova Description and Major Businesses
Table 169. Vaxxinova Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Vaxxinova Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Vaxxinova Recent Developments
Table 172. Japfa Comfeed Indonesia Company Information
Table 173. Japfa Comfeed Indonesia Description and Major Businesses
Table 174. Japfa Comfeed Indonesia Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Japfa Comfeed Indonesia Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Japfa Comfeed Indonesia Recent Developments
Table 177. Nisseiken Company Information
Table 178. Nisseiken Description and Major Businesses
Table 179. Nisseiken Inactivated Poultry Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Nisseiken Inactivated Poultry Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Nisseiken Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Inactivated Poultry Vaccine Distributors List
Table 185. Inactivated Poultry Vaccine Customers List
Table 186. Inactivated Poultry Vaccine Market Trends
Table 187. Inactivated Poultry Vaccine Market Drivers
Table 188. Inactivated Poultry Vaccine Market Challenges
Table 189. Inactivated Poultry Vaccine Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Inactivated Poultry Vaccine Product Picture
Figure 2. Global Inactivated Poultry Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Inactivated Poultry Vaccine Market Share by Type in 2022 & 2029
Figure 4. Liquid Vaccines Product Picture
Figure 5. Freeze-Dried Vaccines Product Picture
Figure 6. Global Inactivated Poultry Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Inactivated Poultry Vaccine Market Share by Application in 2022 & 2029
Figure 8. Avian Encephalomyelitis
Figure 9. Chicken Anaemia
Figure 10. Egg Drop Syndrome
Figure 11. Others
Figure 12. Inactivated Poultry Vaccine Report Years Considered
Figure 13. Global Inactivated Poultry Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Inactivated Poultry Vaccine Revenue 2018-2029 (US$ Million)
Figure 15. Global Inactivated Poultry Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 16. Global Inactivated Poultry Vaccine Revenue Market Share by Region (2018-2029)
Figure 17. Global Inactivated Poultry Vaccine Sales 2018-2029 ((K Units)
Figure 18. Global Inactivated Poultry Vaccine Sales Market Share by Region (2018-2029)
Figure 19. US & Canada Inactivated Poultry Vaccine Sales YoY (2018-2029) & (K Units)
Figure 20. US & Canada Inactivated Poultry Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 21. Europe Inactivated Poultry Vaccine Sales YoY (2018-2029) & (K Units)
Figure 22. Europe Inactivated Poultry Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 23. China Inactivated Poultry Vaccine Sales YoY (2018-2029) & (K Units)
Figure 24. China Inactivated Poultry Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Asia (excluding China) Inactivated Poultry Vaccine Sales YoY (2018-2029) & (K Units)
Figure 26. Asia (excluding China) Inactivated Poultry Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Inactivated Poultry Vaccine Sales YoY (2018-2029) & (K Units)
Figure 28. Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue YoY (2018-2029) & (US$ Million)
Figure 29. The Inactivated Poultry Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of Inactivated Poultry Vaccine in the World: Market Share by Inactivated Poultry Vaccine Revenue in 2022
Figure 31. Global Inactivated Poultry Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Inactivated Poultry Vaccine Sales Market Share by Type (2018-2029)
Figure 33. Global Inactivated Poultry Vaccine Revenue Market Share by Type (2018-2029)
Figure 34. Global Inactivated Poultry Vaccine Sales Market Share by Application (2018-2029)
Figure 35. Global Inactivated Poultry Vaccine Revenue Market Share by Application (2018-2029)
Figure 36. US & Canada Inactivated Poultry Vaccine Sales Market Share by Type (2018-2029)
Figure 37. US & Canada Inactivated Poultry Vaccine Revenue Market Share by Type (2018-2029)
Figure 38. US & Canada Inactivated Poultry Vaccine Sales Market Share by Application (2018-2029)
Figure 39. US & Canada Inactivated Poultry Vaccine Revenue Market Share by Application (2018-2029)
Figure 40. US & Canada Inactivated Poultry Vaccine Revenue Share by Country (2018-2029)
Figure 41. US & Canada Inactivated Poultry Vaccine Sales Share by Country (2018-2029)
Figure 42. U.S. Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 43. Canada Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 44. Europe Inactivated Poultry Vaccine Sales Market Share by Type (2018-2029)
Figure 45. Europe Inactivated Poultry Vaccine Revenue Market Share by Type (2018-2029)
Figure 46. Europe Inactivated Poultry Vaccine Sales Market Share by Application (2018-2029)
Figure 47. Europe Inactivated Poultry Vaccine Revenue Market Share by Application (2018-2029)
Figure 48. Europe Inactivated Poultry Vaccine Revenue Share by Country (2018-2029)
Figure 49. Europe Inactivated Poultry Vaccine Sales Share by Country (2018-2029)
Figure 50. Germany Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 51. France Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 52. U.K. Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 53. Italy Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 54. Russia Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 55. China Inactivated Poultry Vaccine Sales Market Share by Type (2018-2029)
Figure 56. China Inactivated Poultry Vaccine Revenue Market Share by Type (2018-2029)
Figure 57. China Inactivated Poultry Vaccine Sales Market Share by Application (2018-2029)
Figure 58. China Inactivated Poultry Vaccine Revenue Market Share by Application (2018-2029)
Figure 59. Asia Inactivated Poultry Vaccine Sales Market Share by Type (2018-2029)
Figure 60. Asia Inactivated Poultry Vaccine Revenue Market Share by Type (2018-2029)
Figure 61. Asia Inactivated Poultry Vaccine Sales Market Share by Application (2018-2029)
Figure 62. Asia Inactivated Poultry Vaccine Revenue Market Share by Application (2018-2029)
Figure 63. Asia Inactivated Poultry Vaccine Revenue Share by Region (2018-2029)
Figure 64. Asia Inactivated Poultry Vaccine Sales Share by Region (2018-2029)
Figure 65. Japan Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 66. South Korea Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 67. China Taiwan Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 68. Southeast Asia Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 69. India Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 70. Middle East, Africa and Latin America Inactivated Poultry Vaccine Sales Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Inactivated Poultry Vaccine Sales Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Inactivated Poultry Vaccine Revenue Share by Country (2018-2029)
Figure 75. Middle East, Africa and Latin America Inactivated Poultry Vaccine Sales Share by Country (2018-2029)
Figure 76. Brazil Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 77. Mexico Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 78. Turkey Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 79. Israel Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 80. GCC Countries Inactivated Poultry Vaccine Revenue (2018-2029) & (US$ Million)
Figure 81. Inactivated Poultry Vaccine Value Chain
Figure 82. Inactivated Poultry Vaccine Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed